Anna Fábián

22PUBLICATIONS
40CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 12, 2026
Predictive value of iron deficiency anaemia on the one-year disease course in inflammatory bowel disease patients in clinical and biochemical remission.

|Aug 11, 2025
Short- and longevity outcome of cyclosporin rescue therapy in severe ulcerative colitis refractory to intravenous corticosteroid treatment.

Bernadett Farkas, Peter Bacsur, Anita Bálint

|Oct 29, 2024
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real-Life Retrospective Multicentre Cohort Study.

Péter Bacsur, Daniel Shaham, Zuzana Serclova

|Oct 28, 2024
Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases.

Péter Bacsur, Tamás Resál, Patrícia Sarlós

|Oct 08, 2024
Comparison of risk of malignancy and predictive value of diagnostic categories defined by Papanicolaou Society of Cytopathology system and WHO reporting system for pancreaticobiliary cytopathology in solid pancreatic lesions.

Béla Vasas, Anna Fábián, Zsófia Bősze

|Mar 25, 2024
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system.

Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál

Pageof 4

Frequent Collaborators

17 joint publications

Renáta Bor

11 joint publications

Anita Bálint

11 joint publications

Klaudia Farkas

11 joint publications

Tamás Molnár